Keros Therapeutics, Inc.
US ˙ NasdaqGM ˙ US4923271013

SecurityKROS / Keros Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership406,666 shares
Latest Disclosed Value $ 4,489,592
Citadel Advisors Llc ownership in KROS / Keros Therapeutics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 406,666 shares of Keros Therapeutics, Inc. (US:KROS) valued at $4,489,593 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 472,520 shares of Keros Therapeutics, Inc.. This represents a change in shares of -13.94% during the quarter. The current value of the position is $4,188,660 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (KROS) in the form of stock options. The firm currently holds call options representing 17,200 of underlying shares valued at $189,888 USD and put options representing 129,900 of underlying shares valued at $1,434,096 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

KROS / Keros Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KEROS THERAPEUTICS COM 492327101 406,666 -65,854 -13.94 4,490 -53.34 0.0007
2026-02-17 2025-12-31 13F KEROS THERAPEUTICS COM 492327101 472,520 296,376 168.26 9,621 245.30 0.0014
2025-11-14 2025-09-30 13F KEROS THERAPEUTICS COM 492327101 176,144 153,246 669.25 2,787 813.44 0.0004
2025-08-14 2025-06-30 13F KEROS THERAPEUTICS COM 492327101 22,898 -168,711 -88.05 306 -84.37 0.0001
2025-05-15 2025-03-31 13F KEROS THERAPEUTICS COM 492327101 191,609 -599,500 -75.78 1,952 -84.41 0.0004
2025-02-14 2024-12-31 13F KEROS THERAPEUTICS COM 492327101 791,109 86,186 12.23 12,523 -69.41 0.0022
2024-11-14 2024-09-30 13F KEROS THERAPEUTICS COM 492327101 704,923 294,439 71.73 40,935 118.21 0.0079
2024-08-14 2024-06-30 13F KEROS THERAPEUTICS COM 492327101 410,484 -39,794 -8.84 18,759 -37.07 0.0038
2024-05-15 2024-03-31 13F KEROS THERAPEUTICS COM 492327101 450,278 -309,890 -40.77 29,808 -1.38 0.0057
2024-02-14 2023-12-31 13F KEROS THERAPEUTICS COM 492327101 760,168 355,019 87.63 30,224 134.00 0.0060
2023-11-14 2023-09-30 13F KEROS THERAPEUTICS COM 492327101 405,149 77,349 23.60 12,916 -1.94 0.0028
2023-08-14 2023-06-30 13F KEROS THERAPEUTICS COM 492327101 327,800 -43,683 -11.76 13,171 -16.97 0.0027
2023-05-15 2023-03-31 13F KEROS THERAPEUTICS COM 492327101 371,483 -33,988 -8.38 15,862 -18.53 0.0035
2023-02-14 2022-12-31 13F KEROS THERAPEUTICS COM 492327101 405,471 -22,636 -5.29 19,471 20.89 0.0045
2022-11-14 2022-09-30 13F KEROS THERAPEUTICS COM 492327101 428,107 73,753 20.81 16,106 64.50 0.0037
2022-08-15 2022-06-30 13F KEROS THERAPEUTICS COM 492327101 354,354 74,193 26.48 9,791 -35.73 0.0025
2022-05-16 2022-03-31 13F KEROS THERAPEUTICS COM 492327101 280,161 3,059 1.10 15,235 -6.03 0.0031
2022-02-14 2021-12-31 13F KEROS THERAPEUTICS COM 492327101 277,102 2,777 1.01 16,213 49.40 0.0033
2021-11-15 2021-09-30 13F KEROS THERAPEUTICS Cmn 492327101 274,325 156,377 132.58 10,852 116.65 0.0023
2021-08-16 2021-06-30 13F KEROS THERAPEUTICS COM 492327101 117,948 -9,977 -7.80 5,009 -36.38 0.0011
2021-05-21 2021-03-31 13F/A-1 KEROS THERAPEUTICS COM 492327101 127,925 -141,318 -52.49 7,873 -58.55 0.0019
2021-05-17 2021-03-31 13F KEROS THERAPEUTICS COM 492327101 127,925 -141,318 7,873 0.0019
2021-02-16 2020-12-31 13F KEROS THERAPEUTICS COM 492327101 269,243 269,243 18,992 0.0049
2020-11-16 2020-09-30 13F KEROS THERAPEUTICS Cmn 492327101 0 -157,333 -100.00 0 -100.00
2020-08-14 2020-06-30 13F KEROS THERAPEUTICS Cmn 492327101 157,333 157,333 5,901 0.0021
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KEROS THERAPEUTICS COM Call 17,200 -22.52 190 -58.09 n/a n/a n/a
2026-02-17 2025-12-31 13F KEROS THERAPEUTICS COM Call 22,200 1.37 452 30.35 n/a n/a n/a
2025-11-14 2025-09-30 13F KEROS THERAPEUTICS COM Call 21,900 -39.17 346 -27.92 n/a n/a n/a
2025-08-14 2025-06-30 13F KEROS THERAPEUTICS COM Call 36,000 -78.20 481 -71.46 n/a n/a n/a
2025-05-15 2025-03-31 13F KEROS THERAPEUTICS COM Call 165,100 1,079.29 1,682 661.09 n/a n/a n/a
2025-02-14 2024-12-31 13F KEROS THERAPEUTICS COM Call 14,000 23.89 222 -66.31 n/a n/a n/a
2024-11-14 2024-09-30 13F KEROS THERAPEUTICS COM Call 11,300 841.67 656 1,114.81 n/a n/a n/a
2024-08-14 2024-06-30 13F KEROS THERAPEUTICS COM Call 1,200 -90.24 55 -93.37 n/a n/a n/a
2024-05-15 2024-03-31 13F KEROS THERAPEUTICS COM Call 12,300 720.00 814 1,279.66 n/a n/a n/a
2024-02-14 2023-12-31 13F KEROS THERAPEUTICS COM Call 1,500 150.00 60 210.53 n/a n/a n/a
2023-11-14 2023-09-30 13F KEROS THERAPEUTICS COM Call 600 0.00 19 -20.83 n/a n/a n/a
2023-08-14 2023-06-30 13F KEROS THERAPEUTICS COM Call 600 -40.00 24 -42.86 n/a n/a n/a
2023-05-15 2023-03-31 13F KEROS THERAPEUTICS COM Call 1,000 -94.57 43 -95.24 n/a n/a n/a
2023-02-14 2022-12-31 13F KEROS THERAPEUTICS COM Call 18,400 -28.68 884 -9.06 n/a n/a n/a
2022-11-14 2022-09-30 13F KEROS THERAPEUTICS COM Call 25,800 47.43 971 100.62 n/a n/a n/a
2022-08-15 2022-06-30 13F KEROS THERAPEUTICS COM Call 17,500 146.48 484 25.39 n/a n/a n/a
2022-05-16 2022-03-31 13F KEROS THERAPEUTICS COM Call 7,100 -72.90 386 -74.82 n/a n/a n/a
2022-02-14 2021-12-31 13F KEROS THERAPEUTICS COM Call 26,200 1,533 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KEROS THERAPEUTICS COM Put 129,900 -36.14 1,434 -65.37 n/a n/a n/a
2026-02-17 2025-12-31 13F KEROS THERAPEUTICS COM Put 203,400 334.62 4,141 459.59 n/a n/a n/a
2025-11-14 2025-09-30 13F KEROS THERAPEUTICS COM Put 46,800 -36.15 740 -24.34 n/a n/a n/a
2025-08-14 2025-06-30 13F KEROS THERAPEUTICS COM Put 73,300 -47.15 979 -30.79 n/a n/a n/a
2025-05-15 2025-03-31 13F KEROS THERAPEUTICS COM Put 138,700 118.43 1,413 40.60 n/a n/a n/a
2025-02-14 2024-12-31 13F KEROS THERAPEUTICS COM Put 63,500 1,098.11 1,005 227.36 n/a n/a n/a
2024-11-14 2024-09-30 13F KEROS THERAPEUTICS COM Put 5,300 194.44 308 274.39 n/a n/a n/a
2024-08-14 2024-06-30 13F KEROS THERAPEUTICS COM Put 1,800 -64.00 82 -75.23 n/a n/a n/a
2024-05-15 2024-03-31 13F KEROS THERAPEUTICS COM Put 5,000 138.10 331 298.80 n/a n/a n/a
2024-02-14 2023-12-31 13F KEROS THERAPEUTICS COM Put 2,100 2,000.00 83 2,666.67 n/a n/a n/a
2023-11-14 2023-09-30 13F KEROS THERAPEUTICS COM Put 100 -80.00 3 -85.00 n/a n/a n/a
2023-08-14 2023-06-30 13F KEROS THERAPEUTICS COM Put 500 400.00 20 400.00 n/a n/a n/a
2023-05-15 2023-03-31 13F KEROS THERAPEUTICS COM Put 100 4 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.